Indications approved in Europe for biosimilars [93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118]. ANE = anemia; CHM = chemotherapy; CHOP = cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone; CLL = chronic lymphocytic leukemia; EBC = early breast cancer; FN = febrile neutropenia; GPA = granulomatosis with polyangiitis; HER2 = human epidermal growth factor receptor 2; MBC = metastatic breast cancer; ML = myeloid leukemia; MPA = microscopic polyangiitis; PBPC = peripheral blood progenitor cell; n-HL = non-Hodgkin lymphoma; NTP = neutropenia.